SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-18-063387
Filing Date
2018-12-06
Accepted
2018-12-06 16:35:59
Documents
1
Period of Report
2017-07-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv508580_3a.html 3/A  
1 OWNERSHIP DOCUMENT tv508580_3a.xml 3/A 3750
  Complete submission text file 0001144204-18-063387.txt   5392
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Issuer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9TH FLOOR, BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233
Business Address 9TH FLOOR, BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233 86 21 23138051
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Reporting) CIK: 0001615258 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-36577 | Film No.: 181221102